 Home > Medical News > Medicines Company News > FDA agrees to Phase III pivotal clinical trial of procrulamide for the treatment of hospitalized male and female patients with new crown

FDA agrees to Phase III pivotal clinical trial of procrulamide for the treatment of hospitalized male and female patients with new crown

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

male female adapter

phase 4 trial

supplements fda approved

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Development Pharmaceutical Co.
, Ltd.
announced on May 18 that the U.
S.
FDA has approved a Phase III pivotal clinical trial of Prokalamide for the treatment of male and female patients with COVID-19 in hospital
.

At the same time, the FDA agreed to expand the inclusion of female patients in the phase III pivotal clinical trial of Prokalamide for mild and moderate new crowns

Dr.
Tong Youzhi, founder, chairman and CEO of Pioneer Pharmaceuticals, said: “The company plans to carry out a key global multi-center phase III clinical trial of Prokalamide for the treatment of hospitalized patients with new crown in nearly 10 countries around the world.
The US FDA first agreed The implementation of this phase III clinical trial program will help advance the entire clinical process
.

At the same time, the FDA agreed to include female subjects in the previously approved phase III clinical trial of mild and moderate new coronary disease, which means that Prokalamide is expected Benefit more patients

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.